Synthesis and In Silico Study of Some New -[1,3,4]thiadiazolimines and -Thiazolimines As Potential Inhibitors for SARS-CoV-2 Main Protease
Overview
Authors
Affiliations
A novel series of -[1,3,4]thiadiazolimines, and -thiazolimines, with alkyl linker, were synthesized through general routes from cyclization of 1,1'-(hexane-1,6-diyl)bis(3-phenylthiourea) and hydrazonoyl halides or -haloketones, respectively. Docking studies were applied to test the binding affinity of the synthesized products against the M of SARS-CoV-2. The best compound, , has average binding energy (-7.50 ± 0.58 kcal/mol) better than that of the positive controls O6K and N3 (-7.36 ± 0.34 and -6.36 ± 0.31 kcal/mol). Additionally, the docking poses (H-bonds and hydrophobic contacts) of the tested compounds against the M using the PLIP web server were analyzed.
Alrehaily A, Elfiky A, Ibrahim I, Ibrahim M, Sonousi A Sci Rep. 2023; 13(1):23080.
PMID: 38155165 PMC: 10754943. DOI: 10.1038/s41598-023-49712-y.
Abdellattif M, Hamed E, Elhoseni N, Assy M, Emwas A, Jaremko M Sci Rep. 2023; 13(1):19170.
PMID: 37932273 PMC: 10628256. DOI: 10.1038/s41598-023-43575-z.
Alghamdi A, Abouzied A, Alamri A, Anwar S, Ansari M, Khadra I Curr Issues Mol Biol. 2023; 45(2):1422-1442.
PMID: 36826038 PMC: 9955078. DOI: 10.3390/cimb45020093.